Astrotech Corp's ability to collect accounts receivable sequentially worsen to 2.73, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Astrotech's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 134 days, from 113 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 450 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2722, from overall ranking in the second quarter 2025 at 3092.

What is Receivable Turnover Ratio?
What is Astrotech Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ASTC Receivables Turnover Ratio	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter	(Mar 31 2025) III. Quarter
Y / Y Receivable Change	-2.33 %	-60.88 %	289.01 %	529.87 %	156.72 %
Y / Y Revenue Change	-35.77 %	-43.3 %	773.53 %	197.3 %	968 %
Receivable Turnover Ratio (TTM)	2.73	3.22	3.1	2.93	3.53
ASTC's Total Ranking	# 2722	# 3092	# 2720	# 2854	# 3249
Accounts Receivable average collection period days	134	113	118	125	103
Seq. Receivable Change	278.95 %	-62.43 %	-27.01 %	-6.01 %	51.76 %
Seq. Revenue Change	131.76 %	-50.17 %	35 %	-58.8 %	104.6 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 20
Healthcare Sector	# 451
Overall Market	# 2722

Receivable Turnover Ratio Statistics
High	Average	Low
13.61	5.56	0.81
(March 31, 2015)		(Mar 31 2020)

ASTC Company Profile • Back to ASTC Efficiency Comparisons • Compare ASTC Receivables Turnover Ratio to its Competitors

Financial Statements
Astrotech's Accounts Receivable	$ 1 Millions	Visit ASTC's Balance sheet
Astrotech's Sales TTM	$ 1 Millions	Visit ASTC's Income Statement
Sources of ASTC's Revenues		Visit ASTC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ASTC's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ASTC's Growth Rates	ASTC's Roa	ASTC's Inventory Turnover Ratio	ASTC's Dividend Comparisons
ASTC's Profitability Ratios	ASTC's Roi	ASTC's Asset Turnover Ratio	ASTC's Dividend Growth
ASTC's Valuation Ratios	ASTC's Roe	ASTC's Financial Strength Ratios	ASTC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Merck and Co Inc	5.49	$ 65,768.000 Millions	$ 11,987.750 Millions
Johnson and Johnson	5.48	$ 96,362.000 Millions	$ 17,589.000 Millions
Zai Lab Limited	5.43	$ 453.280 Millions	$ 83.515 Millions
Sintx Technologies Inc	5.42	$ 1.029 Millions	$ 0.190 Millions
Pluri Inc	5.41	$ 1.079 Millions	$ 0.200 Millions
Kyntra Bio Inc	5.40	$ 7.439 Millions	$ 1.378 Millions
Alnylam Pharmaceuticals Inc	5.37	$ 4,286.923 Millions	$ 798.351 Millions
Karyopharm Therapeutics Inc	5.29	$ 151.118 Millions	$ 28.586 Millions
The Cooper Companies Inc	5.23	$ 4,230.400 Millions	$ 809.400 Millions
Exagen Inc	5.22	$ 67.881 Millions	$ 12.998 Millions
West Pharmaceutical Services Inc	5.22	$ 3,220.500 Millions	$ 616.850 Millions
Cryoport inc	5.20	$ 182.935 Millions	$ 35.172 Millions
Ultragenyx Pharmaceutical Inc	5.19	$ 669.708 Millions	$ 129.002 Millions
Rxsight Inc	5.19	$ 127.178 Millions	$ 24.509 Millions
Teleflex Incorporated	5.15	$ 2,339.195 Millions	$ 454.393 Millions
Kymera Therapeutics Inc	5.15	$ 51.476 Millions	$ 10.000 Millions
Staar Surgical Co	5.14	$ 290.375 Millions	$ 56.445 Millions
Enovis Corp	5.14	$ 2,275.853 Millions	$ 443.115 Millions
Progyny Inc	5.13	$ 1,292.760 Millions	$ 252.064 Millions
Sangamo Therapeutics Inc	5.12	$ 34.557 Millions	$ 6.744 Millions
Sarepta Therapeutics Inc	5.09	$ 2,184.184 Millions	$ 429.021 Millions
Quanterix Corporation	5.09	$ 144.110 Millions	$ 28.332 Millions
Verrica Pharmaceuticals Inc	5.09	$ 37.161 Millions	$ 7.306 Millions
Ligand Pharmaceuticals Incorporated	5.08	$ 274.476 Millions	$ 54.014 Millions
Invivyd Inc	5.07	$ 55.866 Millions	$ 11.029 Millions
Zimmer Biomet Holdings Inc	5.06	$ 8,409.100 Millions	$ 1,660.650 Millions
Anteris Technologies Global Corp	5.06	$ 1.851 Millions	$ 0.366 Millions
Amgen Inc	5.06	$ 45,369.000 Millions	$ 8,974.750 Millions
Amphastar Pharmaceuticals Inc	5.05	$ 720.530 Millions	$ 142.800 Millions
Protagonist Therapeutics inc	5.03	$ 74.063 Millions	$ 14.721 Millions

Date modified: 2026-08-29T17:13:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.